Zidovudine

colony stimulating factor 2 ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 12043074 [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain]. 2002 Apr 9 1
2 12153332 Clinical implications of CNS penetration of antiretroviral drugs. 2002 1
3 9190855 The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine? 1997 Jun 1
4 8844019 Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. 1996 Aug 10 2
5 9013366 Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: the effects of zidovudine. 1996 Dec 2
6 7498365 Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF. 1995 Dec 1
7 8786245 Oral and intravenous zidovudine pharmacokinetics: the effect of granulocyte-macrophage colony stimulating factor. 1995 Sep 4
8 7875151 Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team. 1994 1
9 7947290 Possible role of granulocyte-macrophage colony stimulating factor (GM-CSF) on the rapid progression of AIDS-related Kaposi's sarcoma lesions in vivo. 1994 Jun 1
10 7962659 Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor. 1994 Sep 1
11 8460920 Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex. 1993 Mar 5
12 1322645 Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages. 1992 Apr 3
13 1380256 Hematopoietic growth factors as adjuncts to antiretroviral therapy. 1992 Jun 1
14 1492010 Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection. 1992 2
15 1634925 Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. 1992 Aug 2
16 1676045 A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection. 1991 Jul 1
17 1713806 The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies. 1991 1
18 1742482 Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. 1991 Dec 15 2
19 2016623 Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. 1991 May 3
20 2018046 Antiretroviral therapy and immunomodulators in patients with AIDS. 1991 Apr 10 2
21 2022593 The use of hematopoietic hormones in HIV infection and AIDS-related malignancies. 1991 Apr 1
22 2048563 GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma. 1991 2
23 2178702 Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. 1990 Mar 15 1
24 2198662 Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease. 1990 Jul 2
25 2198957 Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. 1990 Aug 1 1
26 2223241 Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. 1990 Aug 2
27 2237134 Management of the hematologic complications of human immunodeficiency virus infection. 1990 Sep-Oct 2
28 2260992 Effects of granulocyte-macrophage colony-stimulating factor on 3'-azido-3'-deoxythymidine uptake, phosphorylation and nucleotide retention in human U-937 cells. 1990 Dec 15 7
29 2405493 Status of colony-stimulating factors in cancer and AIDS. 1990 Feb 1
30 2514735 The role of immunomodulators in the treatment of patients with AIDS. 1989 1
31 2538549 Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. 1989 Mar 1 5
32 2783247 The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. 1989 Jan 2